About GenEp
GenEp is a Healthcare company based in Charlottesville (United States) founded in 2021. Therapeutics for epilepsy are developed targeting ion channel mutations. GenEp has raised $10.4 million across 3 funding rounds from investors including University of Virginia, 3B Future Health Fund and Kids Connect Charitable Fund. Its chief executive, as recorded, is Andrew J Krouse. Its focus areas include Life Sciences, Neurology, Drugs and Epilepsy. Its competitors include Marinus Pharma, Epygenix and PrevEp; 1 of its 3 listed competitors has raised funding.
Company details
GenEp was founded in 2021 in Charlottesville, United States, within the biotechnology sector. Therapeutics for epilepsy treatment are developed, with a focus on mutations in sodium and other ion channels. Rare genetic epilepsies and treatment-resistant forms are addressed through these targeted therapies. Operations center on creating solutions for unmet needs in epilepsy care.
- Headquarters Charlottesville, United States
- SectorsHealthcare
- Website genepbio.com
- Total Equity Funding$10.4M (USD)
in 3 rounds
- Latest Funding Round$4M (USD), Series A
Jul 2024
- InvestorsUniversity of Virginia
& 4 more
Funding Insights of GenEp
GenEp has successfully raised a total of $10.4M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $4 million completed in July 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $10.4M
- Total Rounds 3
- Last Round Series A — $4M
- First Round $1.45M
(Oct 2021)
- Investors Count 5
All 3 funding rounds of GenEp with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2024 | $4M | Series A | – | – | – |
| May 2023 | $4.96M | Series A | – | – | – |
| Oct 2021 | $1.45M | Seed | – | University of Virginia, 3B Future Health Fund |
5 investors in total: 5 institutional.
Investors in GenEp
GenEp has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include University of Virginia, 3B Future Health Fund and Kids Connect Charitable Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early-stage healthcare investments are made by 3B Future Health Fund. | 3bfuturehealth.com | Luxembourg, Luxembourg | ||
Angelini Ventures is focused on investing in BioTech and Digital Health. | angeliniventures.com | Rome, Italy | ||
Multiple courses and degrees across diversified streams are offered. | 1819 | virginia.edu | United States | |
Kids Connect Charitable Fund is focused on pediatric health research. | 1998 | kidsconnectfund.org | ||
| pdiventures.com |
Investor details for GenEp
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of GenEp
1 people are tracked at GenEp (1 in leadership).
| Name | Role | Group |
|---|---|---|
Andrew J Krouse | CEO | Leadership |
Complete people profiles for GenEp
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of GenEp
3 dated milestones of GenEp across 3 years, from founding to its latest funding, stage changes and deals.
- Founded GenEp is founded.
- Funding First funding round of $1.4M.
- Funding Latest funding round, Series A, of $4.0M.
Competitors of GenEp
GenEp has 3 listed competitors in our database, 1 of them funded. They include Marinus Pharma, Epygenix and PrevEp.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| marinuspharma.com | 2003 | Radnor, United States | $71.58M | 114 | Developer of therapeutics to treat seizure disorders | |
| epygenix.com | 2016 | Paramus, United States | Develops drugs for rare neurological disorders including sleep, neurobehavioral, and epilepsy conditions. | |||
| prevep.com | 2018 | Bethesda, United States | Therapeutics for preventing epilepsy after brain injury are developed. |
Detailed competitors of GenEp
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Neurology
3 companies that operate in the same segment as GenEp (Neurology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed. | 2013 | San Francisco, California, United States | USD 214.78 M | USD 21.05 M | 211 | |
Developer of therapeutics for psychiatric and neurologic diseases | 2002 | New York, New York, United States | USD 80.87 M | USD 250.31 M | 600 | |
Biologics platform developed for intracellular delivery in rare diseases. | 2016 | Boston, Massachusetts, United States | USD 175.25 M | USD 25.42 M | 183 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about GenEp
GenEp was founded in 2021.
GenEp is headquartered in Charlottesville, United States. It is registered at Charlottesville, Virginia, United States.
Andrew J Krouse is the CEO of GenEp, as recorded in our data.
GenEp is a funded company, having raised a total of $10.4M across 3 funding rounds to date. The company's 1st funding round was a Seed of $1.45M, raised on Oct 2021.
GenEp was founded in 2021 in Charlottesville, United States, within the biotechnology sector. Therapeutics for epilepsy treatment are developed, with a focus on mutations in sodium and other ion channels. Rare genetic epilepsies and treatment-resistant forms are addressed through these targeted therapies. Operations center on creating solutions for unmet needs in epilepsy care.
GenEp's top competitors include Marinus Pharma, PrevEp and Epygenix.
GenEp has 5 investors. Key investors include University of Virginia, 3B Future Health Fund, Kids Connect Charitable Fund, Angelini Ventures, and PDI Ventures.